Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin-enhancing vanadium(III) complexes.

M Melchior1, S J Rettig, B D Liboiron

  • 1Medicinal Inorganic Chemistry Group, Department of Chemistry and Faculty of Pharmaceutical Sciences, University of British Columbia, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.

Inorganic Chemistry
|August 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experience of financial hardship and depression: a longitudinal population-based multi-state analysis.

Epidemiology and psychiatric sciences·2025
Same author

Resilient outcomes in people with a history of mental disorder during the COVID-19 pandemic: an international 2-years longitudinal prospective study.

Social psychiatry and psychiatric epidemiology·2025
Same author

A qualitative evaluation of the use of Problem Management Plus (PM+) among Arabic-speaking migrants with psychological distress in France - The APEX study.

European journal of psychotraumatology·2024
Same author

Remote mental health care interventions during the COVID-19 pandemic: An umbrella review.

Behaviour research and therapy·2022
Same author

Improved separation scheme for <sup>44</sup>Sc produced by irradiation of <sup>nat</sup>Ca targets with 12.8 MeV protons.

Nuclear medicine and biology·2021
Same author

Maternal post-natal depressive symptoms at 2 months: Effects of French antenatal preventive measures in the E.L.F.E. cohort.

Journal of affective disorders·2021
Same journal

Design and Synthesis of Coumarin-Functionalized Zn(II) Phthalocyanine: DFT Analysis, Photophysical, and Photodiode Properties.

Inorganic chemistry·2026
Same journal

Structure-Directed Two-Dimensional {Eu<sub>2</sub>} Metal-Organic Framework with Cooperative Acid-Base Microenvironments for Dual Catalysis and DFT Calculations.

Inorganic chemistry·2026
Same journal

K<sub>3</sub>Yb<sub>2</sub>(BO<sub>3</sub>)<sub>3</sub> and Rb<sub>3</sub>Yb<sub>2</sub>(BO<sub>3</sub>)<sub>3</sub>: Two Rare-Earth Borate Ultraviolet Nonlinear Optical Crystals.

Inorganic chemistry·2026
Same journal

Solid-State and Aqueous Ion-Exchange Reactions of Layered KInSnS<sub>4</sub> and NaInSnS<sub>4</sub> Compounds and Ionic Conductivities of AInSnS<sub>4</sub> (A = Li, Na, K, Rb, Cs, Tl) Compounds at Room Temperature.

Inorganic chemistry·2026
Same journal

Connectivity-Driven Electronic Structure and Charge Separation in Morpholinium-Based Bi<sup>3+</sup>/Sb<sup>3+</sup> Halides.

Inorganic chemistry·2026
Same journal

Incorporating Mono- and Trivalent Thallium Cations into Trivalent Lanthanide Squarate and Squarate-Oxalate Complexes.

Inorganic chemistry·2026
See all related articles

New vanadium(III) complexes, including tris(maltolato)vanadium(III) (V(ma)3) and others, were synthesized. These compounds showed potential for normalizing glucose levels in diabetic rats, similar to the insulin-enhancing agent BMOV.

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Vanadium complexes are investigated for their insulin-mimetic properties.
  • Developing novel vanadium compounds for diabetes management is an ongoing research area.
  • Bis(maltolato)oxovanadium(IV) (BMOV) is a known insulin-enhancing agent used as a benchmark.

Purpose of the Study:

  • To synthesize and characterize novel vanadium(III) complexes.
  • To evaluate the efficacy of these V(III) complexes in normalizing glucose levels in a diabetic rat model.
  • To compare the glucose-normalizing effects of V(III) complexes with BMOV.

Main Methods:

  • Synthesis of V(III) complexes: tris(maltolato)vanadium(III) (V(ma)3), tris(ethylmaltolato)vanadium(III) (V(ema)3), tris(kojato)vanadium(III) monohydrate (V(koj)3-H2O), and tris(1,2-dimethyl-3-hydroxy-4-pyridinonato)vanadium(III) dodecahydrate (V(dpp)3-12H2O).

Related Experiment Videos

  • Characterization using various analytical methods, including X-ray crystal structure determination for V(dpp)3-12H2O.
  • In vivo study using the streptozotocin (STZ)-diabetic rat model to assess glucose-lowering effects.

    • Main Results:

    • Successful high-yield, large-scale synthesis of four distinct V(III) complexes.
    • Comprehensive characterization of the synthesized V(III) complexes.
    • Demonstrated ability of the V(III) complexes to normalize glucose levels in STZ-diabetic rats.
    • Comparative analysis showing similar glucose-normalizing potential to the benchmark BMOV.

    Conclusions:

    • The synthesized V(III) complexes represent a promising new class of compounds for potential diabetes treatment.
    • These V(III) complexes exhibit significant insulin-enhancing activity in a preclinical model.
    • Further research into these V(III) complexes could lead to novel therapeutic strategies for managing diabetes.